GRIA1 and Alzheimer disease: To further determine potential genotype differences in hippocampal glutamate signaling (a potential molecular mechanism of AD) we measured the GluA1 AMPA receptor subunit at the transcript level, Gria1, across LVR, WT, and HVR.